Jürgen Wolf

First exoplanet transit observation with the Stratospheric Observatory for Infrared Astronomy: confirmation of Rayleigh scattering in HD 189733 b with the High-Speed Imaging Photometer for Occultations

Maureen Savage, Enrico Pfüller, Daniel Angerhausen, 2015, 1507.01866.

USES AND NEEDS REPORT for ORISON ( innOvative Research Infrastructure based on Stratospheric balloONs)

Luis Álvarez, Karsten Schindler, Thomas J. Müller, 2016 .

A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients

Thomas Zander, Martin Kocher, Sebastian Frechen, 2015, The AAPS Journal.

Intracranial and whole-body response of ceritinib in ALK inhibitor-naïve and previously ALK inhibitor-treated patients with ALK-rearranged non-small-cell lung cancer (NSCLC): updated results from the phase 1, multicentre, open-label ASCEND-1 trial

Michael Thomas, Armando Santoro, Martin Schuler, 2016, The Lancet. Oncology.

Blood-Based Gene Expression Signatures in Non–Small Cell Lung Cancer

Thomas Zander, Andrea Hofmann, Joachim L Schultze, 2011, Clinical Cancer Research.

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

Laura Tolosi, Michael Peyton, Thomas Zander, 2009, The Journal of clinical investigation.

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

Martin Vingron, Thomas Zander, Yupeng Cun, 2018, Nature Communications.

Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors

Uwe Fuhr, Jürgen Wolf, U. Fuhr, 2011, Clinical pharmacokinetics.

Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study.

Manuel Hidalgo, Martin Schuler, Fabrice Andre, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Frequent mutations in chromatin-remodeling genes in pulmonary carcinoids

Martin Vingron, Thomas Zander, Viktor Achter, 2014, Nature Communications.

Rationale for co-targeting IGF-1R and ALK in ALK fusion positive lung cancer

William Pao, Zhongming Zhao, Ronglai Shen, 2014, Nature Medicine.

Comprehensive genomic profiles of small cell lung cancer

Martin Vingron, Jan O. Korbel, Lucia Anna Muscarella, 2015, Nature.